GALASTOP 5MG/100ML ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
GALASTOP 5MG/100ML ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Authorised
- Cabergoline
Product identification
Medicine name:
GALASTOP 5MG/100ML ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
- Cabergoline
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cabergoline5.00milligram(s)100.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
- Dog
-
Not applicableno withdrawal period
-
- Cat
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG02CB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Ceva Hellas LLC
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetem S.p.A.
- Ceva Sante Animale
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 53482/19-07-2012/K-0087701
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: